title: Childhood Hib vaccination and pneumonia and influenza burden in US seniors.
abstract: This analysis examines the potential for the elderly to receive indirect protection from pneumonia and influenza (P&I) from vaccination of children. Using data from the Centers for Medicare and Medicaid Services, the National Immunization Survey, and the Behavioral Risk Factor Surveillance System, mixed-effects models were used to assess associations between vaccination coverage and P&I on the state level overall and by urbanicity and income. As vaccination coverage in children increased, the state-level P&I rates in seniors decreased (beta=-0.040, -0.074 to 0.006), where beta represents the expected change in the logged age-associated rate of disease increase for a one-percentage point increase in vaccination coverage. Increasing vaccination coverage in the elderly was associated with an increase in P&I rates (beta=0.045, 0.011-0.077) in seniors. The degree of association was more prominent in urban and high income areas. The consistent associations between influenza in the elderly and vaccination coverage in children suggest that routine vaccination of children may impart some indirect protection to the elderly.
authors.affiliation: Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. steven a.cohen@tufts.edu
authors.forename: Steven A
authors.initials: SA
authors.lastname: Cohen
authors.forename: Saifuddin
authors.initials: S
authors.lastname: Ahmed
authors.forename: Ann C
authors.initials: AC
authors.lastname: Klassen
authors.forename: Emily M
authors.initials: EM
authors.lastname: Agree
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Louis
authors.forename: Elena N
authors.initials: EN
authors.lastname: Naumova
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002675:Child, Preschool; D018073:Haemophilus Vaccines / Q000008:administration & dosage*; D006801:Humans; D032521:Immunity, Herd; D017589:Immunization Programs; D007223:Infant; D007251:Influenza, Human / Q000453:epidemiology* / Q000517:prevention & control; D011014:Pneumonia / Q000453:epidemiology* / Q000517:prevention & control; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000706:statistics & numerical data*
chemical_list: D018073:Haemophilus Vaccines
references.citation: Arch Intern Med. 2005 Feb 14;165(3):265-72
references.pmid: 15710788
references.citation: Clin Microbiol Infect. 2001 Nov;7(11):581-8
references.pmid: 11737082
references.citation: N Engl J Med. 2005 Dec 15;353(24):2559-67
references.pmid: 16354892
references.citation: JAMA. 2005 Dec 7;294(21):2712-9
references.pmid: 16333006
references.citation: Vaccine. 2005 Feb 18;23(13):1540-8
references.pmid: 15694506
references.citation: JAMA. 2004 Sep 15;292(11):1333-40
references.pmid: 15367555
references.citation: J Immunol. 2004 Mar 15;172(6):3437-46
references.pmid: 15004143
references.citation: Am J Prev Med. 2001 May;20(4 Suppl):88-153
references.pmid: 12174806
references.citation: N Engl J Med. 2000 Jan 27;342(4):225-31
references.pmid: 10648763
references.citation: Am J Infect Control. 2005 Dec;33(10):563-70
references.pmid: 16330304
references.citation: Am J Respir Crit Care Med. 1999 Aug;160(2):397-405
references.pmid: 10430704
references.citation: Eur Respir J. 2003 Feb;21(2):294-302
references.pmid: 12608444
references.citation: Lancet. 2005 Oct 1;366(9492):1165-74
references.pmid: 16198765
references.citation: Arch Dis Child. 2002 Jun;86(6):396-9
references.pmid: 12023165
references.citation: Science. 2006 Apr 21;312(5772):447-51
references.pmid: 16574822
references.citation: Stat Med. 2011 Feb 28;30(5):480-8
references.pmid: 21287586
references.citation: Br J Gen Pract. 2004 Sep;54(506):684-9
references.pmid: 15353055
references.citation: Am J Public Health. 1991 Sep;81(9):1166-73
references.pmid: 1951829
references.citation: Clin Infect Dis. 2005 Oct 1;41(7):939-47
references.pmid: 16142657
references.citation: Emerg Infect Dis. 2008 Aug;14(8):1193-9
references.pmid: 18680641
references.citation: Soz Praventivmed. 2001;46 Suppl 1:S3-42
references.pmid: 11851091
references.citation: Biometrics. 1988 Dec;44(4):1049-60
references.pmid: 3233245
references.citation: Pediatr Infect Dis J. 1999 Dec;18(12):1060-4
references.pmid: 10608624
references.citation: Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S202-6
references.pmid: 15577574
references.citation: Vaccine. 2005 Jan 26;23(10):1284-93
references.pmid: 15652671
references.citation: JAMA. 2000 Oct 4;284(13):1677-82
references.pmid: 11015798
references.citation: Arch Pediatr Adolesc Med. 1996 Oct;150(10):1054-61
references.pmid: 8859138
references.citation: Vaccine. 2000 Feb 25;18(16):1686-9
references.pmid: 10689149
references.citation: J Infect Dis. 1970 Jul-Aug;122(1):16-25
references.pmid: 5433709
references.citation: Int J Epidemiol. 2006 Aug;35(4):1044-50
references.pmid: 16723370
references.citation: N Engl J Med. 2001 Mar 22;344(12):889-96
references.pmid: 11259722
references.citation: J Am Geriatr Soc. 2009 Dec;57(12):2192-9
references.pmid: 19874403
references.citation: JAMA. 1992 Feb 12;267(6):823-6
references.pmid: 1732654
references.citation: JAMA. 1993 Jan 13;269(2):221-6
references.pmid: 8417239
references.citation: MMWR Morb Mortal Wkly Rep. 2004 Jul 30;53(29):658-61
references.pmid: 15282449
references.citation: Am J Prev Med. 2001 Jan;20(1):21-5
references.pmid: 11137770
references.citation: J Clin Virol. 2006 Dec;37(4):237-43
references.pmid: 17008123
references.citation: JAMA. 2003 Jan 8;289(2):179-86
references.pmid: 12517228
references.citation: Epidemiol Infect. 2006 Feb;134(1):71-8
references.pmid: 16316494